Related Experiment Videos
Insights
Respiratory syncytial virus (RSV) causes most bronchiolitis cases. While overall hospitalization is low at 1%, high-risk infants face a significantly increased risk, reaching 25%.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Bronchiolitis is a common pediatric respiratory infection.
- Respiratory syncytial virus (RSV) is the primary causative agent.
- Hospitalization rates vary significantly based on underlying health conditions.
Purpose of the Study:
- To summarize the etiology of bronchiolitis.
- To report overall and high-risk hospitalization rates for bronchiolitis.
Main Methods:
- Literature review and data synthesis on bronchiolitis epidemiology.
- Analysis of etiological factors, focusing on viral causes.
- Examination of hospitalization data stratified by patient risk factors.
Main Results:
- Approximately 80% of bronchiolitis cases are attributed to RSV.
- The overall hospitalization rate for bronchiolitis is approximately 1%.
- Hospitalization rates increase to 25% in infants with severe prematurity, bronchopulmonary dysplasia, or congenital heart disease.
Conclusions:
- RSV is the dominant pathogen in bronchiolitis.
- While generally mild, bronchiolitis poses a significant risk for vulnerable infant populations.
- Identifying and monitoring high-risk infants is crucial for managing bronchiolitis severity.
Abstract:
(1) Approximately 80% of cases of bronchiolitis appear to be due to respiratory syncytial virus (RSV). (2) Overall, about 1% of cases of bronchiolitis lead to hospitalisation. This rises to about 25% in children with a history of severe prematurity, bronchopulmonary dysplasia or congenital heart disease.